Results 21 to 30 of about 2,360,518 (263)

NUMERICAL ANALYSIS OF ELECTRIC FORCE DISTRIBUTION ON TUMOR MASS IN DC ELECTRIC FIELD EXPOSURE

Spektra: Jurnal Fisika dan Aplikasinya, 2021
Researchers have used electric fields as a new therapeutic strategy to treat cancer for the past 15 years. Tumor Treating Fields (TTFields) is an alternating electric field-based cancer therapy approved by the US FDA to treat glioblastoma multiforme (GBM)
Muhammad Arif, Warsito Purwo Taruno, Septelia Inawati Wanandi, Anto Sulaksono   +3 more
doaj   +1 more source

Fluid and Bubble Flow Detach Adherent Cancer Cells to Form Spheroids on a Random Positioning Machine

Cells, 2023
In preparing space and microgravity experiments, the utilization of ground-based facilities is common for initial experiments and feasibility studies. One approach to simulating microgravity conditions on Earth is to employ a random positioning machine ...
José Luis Cortés-Sánchez, Daniela Melnik, Viviann Sandt, Stefan Kahlert, Shannon Marchal, Ian R. D. Johnson, Marco Calvaruso, Christian Liemersdorf, Simon L. Wuest, Daniela Grimm, Marcus Krüger   +10 more
doaj   +1 more source

Cancer Cells

Southern Medical Journal, 1956
Includes bibliography. ; Mode of access: Internet.
openaire   +1 more source

An Efficient, Short Stimulus PANC-1 Cancer Cell Ablation and Electrothermal Therapy Driven by Hydrophobic Interactions

Pharmaceutics, 2022
Promising results in clinical studies have been demonstrated by the utilization of electrothermal agents (ETAs) in cancer therapy. However, a difficulty arises from the balance between facilitating the degradation of ETAs, and at the same time ...
Maria P. Meivita, Denise Lee, J Shamita Naikar, Shao-Xiang Go, Wey Chyi Teoh, Yaw Sing Tan, Natasa Bajalovic, Desmond K. Loke   +7 more
doaj   +1 more source

EZH2 Regulates Protein Stability via Recruiting USP7 to Mediate Neuronal Gene Expression in Cancer Cells

Frontiers in Genetics, 2019
Misexpression of chromatin modification factors and changed epigenetic modifications play crucial roles for tumorigenesis. Our previous studies demonstrated that inhibition of epigenetic modification enzymes EZH2, LSD1, DNMTs, and HDACs caused post ...
Anhua Lei, Lu Chen, Min Zhang, Xiaoli Yang, Liyang Xu, Ning Cao, Zan Zhang, Ying Cao   +7 more
doaj   +1 more source

Stem cell-like cancer cells in cancer cell lines

Cancer Biomarkers, 2007
Both stem cells and cancer cells are thought to be capable of unlimited proliferation. Moreover, a small number of cancer cells express stem cell markers, including CD133 and ATP-binding cassette transporters, by which the cells can pump out specific fluorescence dyes, such as Hoechst33342, as well as anti-cancer drugs, suggesting that either cancer ...
openaire   +4 more sources

Polarimetric Detection of Chemotherapy-Induced Cancer Cell Death

Applied Sciences, 2019
Imaging polarimetry is a focus of increasing interest in diagnostic medicine because of its non-destructive nature and its potential to distinguish normal from tumor tissue. However, handling and understanding polarimetric images is not an easy task, and
Andrea Fernández-Pérez, Olga Gutiérrez-Saiz, José Luis Fernández-Luna, Fernando Moreno, José María Saiz   +4 more
doaj   +1 more source

Analysis of vascular smooth muscle cell and HeLa cell migration on the microgrooved substrate (Cell type differences of the mechanical sensing for microgrooved surfaces)

Nihon Kikai Gakkai ronbunshu, 2020
Cell migration is critical in many physiological processes, including morphogenesis, wound healing, and metastasis of cancer cells, and thus elucidation of the mechanism of cell migration is quite important.
Tatsuya HANZAWA, Kazuaki NAGAYAMA
doaj   +1 more source

Enhanced Cellular Uptake and Pharmacokinetic Characteristics of Doxorubicin-Valine Amide Prodrug

Molecules, 2016
In this study, we synthesized the valine (Val)-conjugated amide prodrug of doxorubicin (DOX) by the formation of amide bonds between DOX and Val. The synthesis of the DOX-Val prodrug was identified by a proton nuclear magnetic resonance (1H-NMR) assay ...
Yohan Park, Ju-Hwan Park, Suryeon Park, Song Yi Lee, Kwan Hyung Cho, Dae-Duk Kim, Won-Sik Shim, In-Soo Yoon, Hyun-Jong Cho, Han-Joo Maeng   +9 more
doaj   +1 more source

The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and Switzerland

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background The HIT network was established in 2000 to create a population‐based structure aiming to improve survival rates and reduce late effects for children with central nervous system (CNS) tumors by conducting comprehensive clinical trials.
Stefan Rutkowski, Michael C. Frühwald, Gudrun Fleischhack, Stephan Tippelt, Pablo Hernáiz‐Driever, Olaf Witt, Astrid Gnekow, Christof Kramm, Matthias Eyrich, Johannes E. A. Wolf, Hermann Müller, Carsten Friedrich, Uwe R. Kordes, Denise Obrecht‐Sturm, Petra Ketteler, Barbara von Zezschwitz, Pascal Johann, Dominik Sturm, Karoline Nemes, Stefan Schönberger, Till Milde, Brigitte Bison, Monika Warmuth‐Metz, Torsten Pietsch, Ulrich Schüller, Arend Koch, David Capper, Martin Hasselblatt, Christian Thomas, Christian Hagel, Stefan M. Pfister, Felix Sahm, David T. W. Jones, Martin U. Schuhmann, Jürgen Krauss, Pedram Emami, Ahmed El Damaty, Rolf D. Kortmann, Rudolf Schwarz, Jürgen Debus, Mechthild Krause, Fabian Pohl, Holger Ottensmeier, Lisa Bußenius, Katja Baust, Andreas Faldum, Cecile Ronckers, Desiree Grabow, Martin Benesch, Thomas Perwein, Karin Dieckmann, Irene Slavc, Johannes Gojo, Nicolas U. Gerber, André O. von Bueren, Katrin Scheinemann, Gabriele Calaminus, Beate Timmermann, Ulrich‐Wilhelm Thomale, Martin Mynarek   +59 more
wiley   +1 more source